http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CS-231555-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42408b660e7ccdf2a5a0cd65fdaedbcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c14f253ec5d8231512eb581e7971bdcb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93
filingDate 1979-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80ee35b5d094efe154d732f2838880c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c7eb0948e5d518ee24f031fe5530246
publicationDate 1984-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CS-231555-B1
titleOfInvention Method of epimerization of giberellin-7-aldehydes
abstract The object of the invention is to prepare for the first timengiberellin-7-aldehydes with an aldehyde groupnin a 6X-position to provide a new onena group of biologically active substances.nFurthermore, giberellin-7-aldehydes are labeled with deuteriumnor tritium.nAccording to the invention, giberellin-7-aldebyd is usednwith an aldehyde group in position 6 < 4nor 6/3 - enolize with alkali and additionncompounds with hydrogen donor properties,ndeuteria or tritium react to epimericna mixture consisting of giberellin-7-aldehydenwith an aldehyde group in the W-position angiberellin-7-aldehyde with an aldehyde groupnin the 6-position, while in usendeuterium or tritium donors are bothnthe epimars obtained are labeled on the sixth atomncarbon.nThe process of the invention is generally acceptablenfor all giberellin-7-aldehydes,nwithout changing their sensitive partsnalkali. Labeled according to the inventionnGibberellin-7-aldehydes serve as starting materialnsubstances for the preparation of labeled naturalngiberellins and their derivatives.
priorityDate 1978-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID644191
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID80379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11051814
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID45372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID45372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167583
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID86230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID86230
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID644191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID80379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454468409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524874

Total number of triples: 35.